N/A N=11 Flexibility and Strength Training in Asthma
Asthma
Primary: Forced Expiratory Volume at One Second - FEV1 % Predicted — 91.4; 93.4 % predicted — p=.10
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=20 A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer
Prostate Cancer
Primary: Detection of Metastases — 7; 8; 2; 0 Participants
Phase 4 N=26 Methylphenidate for Attention Problems After Pediatric TBI
Traumatic Brain Injury · TBI · ADHD
Primary: Parent Outcome-Vanderbilt ADHD Parent Rating Scales (VADPRS) — 1.10; 1.47; .84; 1.14 units on a scale
N/A N=248 Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
Mild Traumatic Brain Injury · Posttraumatic Stress Disorders · Depression
Primary: Change in the Community Reintegration of Injured Service Members Computer Adaptive Test (CRIS-CAT) — 36.4; 35.0; 38.2; 35.1 score on a scale
N/A N=77 Micra Atrial TRacking Using A Ventricular AccELerometer 2
Atrioventricular Conduction Block
Primary: Atrial Ventricular Pacing Synchrony Success During Rest — 0; 38; 0; 2 Participants — p=<0.001
Phase 3 N=766 Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy
Epilepsy
Primary: Percentage of Participants With at Least One Treatment-Emergent Adverse Event (TEAE) — 83.9 Percentage of participants
N/A N=150 Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
Breast Cancer
Primary: Compare Per Subject AUC: DBT Plus S-View Versus FFDM — 0.794; 0.764 Probability
Phase 2 N=78 Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Total Body Fat Mass by Dual Energy X-ray Absorptiometry (DXA) at Week 48 — -7.49; -0.18 kg — p=<0.001
N/A N=94,321 Influenza Vaccination Digital Interventions for People Living With Diabetes
Diabetes
Primary: Number of Participants With Self-reported Influenza Vaccination in People With Diabetes — 3310; 1848; 3220; 2051 Participants
N/A N=4 TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study
Cystinuria
Primary: Urinary Cystine Supersaturation (mg/L) at High Dose (Day7-8) — 70 mg/L
Phase 3 N=147 BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
Crohn Disease
Primary: Percentage of Patients With a Clinical Response (CDAI Decrease of ≥70 Compared With Baseline) at Week 4 — 88.0; 93.1 Percentage of participants
Phase 1 N=31 A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil
Epilepsy
Primary: The Maximum Observed Plasma Concentration (Cmax) of Padsevonil (PSL) During the Study — 1210; 1670 ng/mL
Phase 3 N=119 Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
Tourette Syndrome
Primary: Change From Baseline in the TTS of the YGTSS at Week 12 — -9.1; -8.4 units on a scale — p=0.692
N/A N=27 Comparison of Videogame Based Dance Training With Agility Ladder Drills on Agility of Volleyball Players
Healthy Athletes
Primary: Change in Agility From Baseline to 6 Weeks — 1.56; 0.86 Seconds
N/A N=42,491 Mentor MemoryGel Post-Approval Study
Breast Reconstruction · Breast Augmentation · Breast Revision
Primary: Kaplan Meier Estimated Cumulative Incidence of Reported Complications — 0.0; 6.7; 10.8; 11.2 Cumulative Reoperation Events